Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced new data showing ...
Medical Device Network on MSN
Medtronic reports real-world findings for cardiac ablation systems
In the REAL PULSE prospective study, clinicians evaluated 1,160 AFib patients across 38 centres using the PulseSelect PFA system.
A 25-year-old man's recurrent palpitations were finally traced to a rare upper septal fascicular ventricular tachycardia that ...
WASHINGTON, June 1, 2026 /PRNewswire/ -- In recognition of SVT Awareness Day, the Heart Rhythm Society (HRS) and Milestone Pharmaceuticals are partnering to expand supraventricular tachycardia (SVT) ...
For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication. In ...
A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex tachycardias. Ablation procedures use energy—usually heat or cold—to eliminate ...
Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for patients who do not improve with medication, may be a better first-line treatment ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results